Honasa Consumer acquires 58% of Fluence Pharma at Rs 135 cr EV, launches Honasa Health subsidiary
Mamaearth parent Honasa Consumer is buying a controlling 58% stake in Mumbai-based nutraceuticals brand Fluence Pharma at Rs 135 crore enterprise value, with plans to acquire the remaining 42% over 5-7 years. Fluence becomes the 9th brand in Honasa's portfolio and the first under newly-formed Honasa Health subsidiary.
Honasa Consumer is acquiring 58% of Mumbai-based nutraceuticals brand Fluence Pharma at Rs 135 crore EV, with plans to buy the rest over 5-7 years. Fluence becomes the ninth brand in Honasa's portfolio under new subsidiary Honasa Health.
Why this matters
Mamaearth parent Honasa extends beyond beauty and personal care into nutraceuticals, marking its first move into the Rs 16,000 cr beauty-from-within category via a dedicated Honasa Health vertical.
Retail-company activity steady with 3,584 signals over the last 90 days.